Learn More about Thrombosis and Thrombophilia
According to the US Surgeon General the incidence of deep vein
thrombosis (DVT) and pulmonary
embolism ranges between 350,000 to
600,000 per year with an estimated 100,000 deaths per year. Recent
numbers from a study by Dr. John Heit from the Mayo Clinic suggest the
numbers may be much higher. While the statistics may vary the numbers are
staggering. NATT is working every day to increase awareness about
thrombosis and thrombophilia and help to "Stop the Clot".
Click here to view our
interactive map. What ever the numbers, most of these lives could have been saved if more patients
and health professionals had known about
the
symptoms, risks, and
treatments.
A to Z Thrombosis and Thrombophilia Index:
- Air Travel and Thrombosis
- Antithrombin Deficiency: An In-Depth Guide for Patient and Health Care Providers
- Antiphospholipid Syndrome
- Athletes and Blood Clots
- Blood Clot Treatment
- Blood Clots in Children
- Blood Clots - Drug and Food Interactions - What You Should Know
- Blood Clot Follow-up Care
- Blood Clots and Women's Health
- Blood Clot Treatment FAQ
- Common Questions about Blood Clots
- Congenital Thrombophilia
- Deep Vein Thrombosis and Pulmonary Embolism
- Deep Vein Thrombosis
- Deep Vein Thrombosis Blood Clot Symptoms
- DVT Incidence Map
- Everything You Ever Wanted
to Know About Blood Clotting. NATT Video Series.
- Family Testing for Clotting Disorders
- Factor V Leiden For Kids
- Genetics of Thrombophilia - PDF
- Glossary of Common Blood Clotting Terms
- Inherited antithrombin deficiency: a review
- Major Blood Clotting Research Areas
- Our Genes Our Stories - NATT
Video Series
- Patient Stories
- Pregnancy Outcome, Thromboembolism and Thrombophilia
- Prevention of Thrombosis
- Postthrombotic Syndrome
- Special Blood Clotting Situations
- Symptoms
- The Genetics of Thrombophilia
- Thrombophilia
- Thrombosis and Thrombophilia Blood Clot Testing and Diagnosis
- Thrombosis and Thrombophilia Blood Clot Risk Factors
- Treatment of Thrombosis
- Thrombic Storm
- UPDATE: REGARDING NEW ORAL ANTICOAGULANTS FROM A PATIENT PERSPECTIVE
- Vitamin K and Warfarin
- Venous Stress Disorder
- What GINA does and does not mean
- What is Thrombophilia?
- Your Guide to Coumadin / Warfarin Therapy - An AHRQ Publication
NATT Newsletters
Other Resources
Research
One of NATT's key objectives is to “promote and assist with research efforts relating to all aspects of thrombosis and thrombophilia."
Clinical Trials
Patients are needed to participate in ongoing research to learn more about risk factors, treatment and prevention of thrombosis. To learn more about clinical investigations underway related to thrombosis and thrombophilia, click on the following links:
Clinical trials - Thrombophilia
was not recognized by their treating physician until they were near death.
Many of these patients had thrombophilia - an inherited condition that makes
people more prone to blood clots. NATT has assembled a comprehensive set of resources for patients and health professionals designed to increase awareness and "Stop the Clot".
created a section specifically for health professionals in our "
